These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 7087161)
1. Effect of the vasodilator therapy in regurgitant valvular disease. Sasayama S; Ohyagi A; Lee JD; Nonogi H; Sakurai T; Wakabayashi A; Fujita M; Kawai C Jpn Circ J; 1982 Apr; 46(4):433-41. PubMed ID: 7087161 [TBL] [Abstract][Full Text] [Related]
2. Afterload reduction therapy with nitroprusside in severe aortic regurgitation: improved cardiac performance and reduced regurgitant volume. Miller RR; Vismara LA; DeMaria AN; Salel AF; Mason DT Am J Cardiol; 1976 Nov; 38(5):564-7. PubMed ID: 983953 [TBL] [Abstract][Full Text] [Related]
3. Hemodynamic consequences of afterload reduction in patients with chronic aortic regurgitation. Bolen JL; Alderman EL Circulation; 1976 May; 53(5):879-83. PubMed ID: 1260993 [TBL] [Abstract][Full Text] [Related]
4. Comparison of intraoperative nitroprusside unloading in mitral and aortic regurgitation. Stone JG; Hoar PF; Faltas AN; Johnson LL; Edie RN; Bowman FO; Malm JR J Thorac Cardiovasc Surg; 1979 Jul; 78(1):103-9. PubMed ID: 449373 [TBL] [Abstract][Full Text] [Related]
5. Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves. Levine HJ; Gaasch WH J Am Coll Cardiol; 1996 Nov; 28(5):1083-91. PubMed ID: 8890799 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of reduction of mitral regurgitation with vasodilator therapy. Yoran C; Yellin EL; Becker RM; Gabbay S; Frater RW; Sonnenblick EH Am J Cardiol; 1979 Apr; 43(4):773-7. PubMed ID: 425914 [TBL] [Abstract][Full Text] [Related]
7. Contribution of reduced mitral regurgitant volume to vasodilator effect in severe left ventricular failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. Weiland DS; Konstam MA; Salem DN; Martin TT; Cohen SR; Zile MR; Das D Am J Cardiol; 1986 Nov; 58(10):1046-50. PubMed ID: 3776843 [TBL] [Abstract][Full Text] [Related]
8. Afterload reduction with vasodilators and diuretics decreases mitral regurgitation during upright exercise in advanced heart failure. Stevenson LW; Brunken RC; Belil D; Grover-McKay M; Schwaiger M; Schelbert HR; Tillisch JH J Am Coll Cardiol; 1990 Jan; 15(1):174-80. PubMed ID: 2295730 [TBL] [Abstract][Full Text] [Related]
9. Reduced systemic vascular resistance as therapy for severe mitral regurgitation of valvular origin. Harshaw CW; Grossman W; Munro AB; McLaurin LP Ann Intern Med; 1975 Sep; 83(3):312-6. PubMed ID: 1180426 [TBL] [Abstract][Full Text] [Related]
10. Hemodynamic and morphologic changes after long-term angiotensin converting enzyme inhibition in patients with chronic valvular regurgitation. Schön HR J Hypertens Suppl; 1994 Jul; 12(4):S95-104. PubMed ID: 7965280 [TBL] [Abstract][Full Text] [Related]
11. Dynamic aspects of acute mitral regurgitation: effects of ventricular volume, pressure and contractility on the effective regurgitant orifice area. Yoran C; Yellin EL; Becker RM; Gabbay S; Frater RW; Sonnenblick EH Circulation; 1979 Jul; 60(1):170-6. PubMed ID: 445720 [TBL] [Abstract][Full Text] [Related]
12. [The relationships between left ventricular volumes and ejection fraction in mitral and aortic regurgitation (author's transl)]. Strauer BE; Kramer H; Bolte H; Riecker G Klin Wochenschr; 1975 Oct; 53(20):795-84. PubMed ID: 1202276 [TBL] [Abstract][Full Text] [Related]
13. Myocardial mechanics in aortic and mitral valvular regurgitation: the concept of instantaneous impedance as a determinant of the performance of the intact heart. Urschel CW; Covell JW; Sonnenblick EH; Ross J; Braunwald E J Clin Invest; 1968 Apr; 47(4):867-83. PubMed ID: 5641623 [TBL] [Abstract][Full Text] [Related]
14. Effects of afterload reduction on vena contracta width in mitral regurgitation. Kizilbash AM; Willett DL; Brickner ME; Heinle SK; Grayburn PA J Am Coll Cardiol; 1998 Aug; 32(2):427-31. PubMed ID: 9708471 [TBL] [Abstract][Full Text] [Related]
15. Load dependence of the effective regurgitant orifice area in a sheep model of aortic regurgitation. Reimold SC; Byrne JG; Caguioa ES; Lee CC; Laurence RG; Peigh PS; Cohn LH; Lee RT J Am Coll Cardiol; 1991 Oct; 18(4):1085-90. PubMed ID: 1832697 [TBL] [Abstract][Full Text] [Related]
16. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Capomolla S; Febo O; Gnemmi M; Riccardi G; Opasich C; Caporotondi A; Mortara A; Pinna GD; Cobelli F Am Heart J; 2000 Apr; 139(4):596-608. PubMed ID: 10740140 [TBL] [Abstract][Full Text] [Related]
17. Beneficial effects of hydralazine in severe mitral regurgitation. Greenberg BH; Massie BM; Brundage BH; Botvinick EH; Parmley WW; Chatterjee K Circulation; 1978 Aug; 58(2):273-9. PubMed ID: 668075 [TBL] [Abstract][Full Text] [Related]
18. Noninvasive assessment of acute effects of nifedipine on rest and exercise hemodynamics and cardiac function in patients with aortic regurgitation. Shen WF; Roubin GS; Hirasawa K; Uren RF; Hutton BF; Harris PJ; Fletcher PJ; Kelly DT J Am Coll Cardiol; 1984 Nov; 4(5):902-7. PubMed ID: 6491083 [TBL] [Abstract][Full Text] [Related]
19. Effects of heart rate on experimentally produced mitral regurgitation in dogs. Yoran C; Yellin EL; Hori M; Tsujioka K; Laniado S; Sonnenblick EH; Frater RW Am J Cardiol; 1983 Dec; 52(10):1345-9. PubMed ID: 6650422 [TBL] [Abstract][Full Text] [Related]
20. Pilot study to assess the influence of beta-blockade on mitral regurgitant volume and left ventricular work in degenerative mitral valve disease. Stewart RA; Raffel OC; Kerr AJ; Gabriel R; Zeng I; Young AA; Cowan BR Circulation; 2008 Sep; 118(10):1041-6. PubMed ID: 18725484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]